Medication info
Teddy-PM Extended Release Tablet 10/750 mg

Teddy-PM Extended Release Tablet 10/750 mg

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›13mg / 1 tabletMetformin Hydrochloride›750mg / 1 tablet
Manufacturer / importer
Dongkwang Pharmaceutical Co., Ltd.
Appearance
Yellow oval extended release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202201498 · Approved 2022.04.08 · Insurance code 645907310

Summary

Main use
Improves blood glucose control in patients with type 2 diabetes
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients who are unable to achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current dose of metformin. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be started at the patient's current doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and the dose adjusted as appropriate. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other glucose-lowering agents. Since such changes may cause alterations in glycemic control, any changes in the treatment of patients with type 2 diabetes mellitus should be made under close monitoring. To maintain its extended-release properties, this medicine should be swallowed whole and must not be split, crushed, ground, or chewed.

Ingredients

Manufacturer
Dongkwang Pharmaceutical Co., Ltd.

Efficacy & effects

Improves blood glucose control in patients with type 2 diabetes

View approved original text

This medication is used in conjunction with dietary therapy and exercise therapy to help control blood glucose levels in patients with type 2 diabetes. Teneligliptin and metformin work together to effectively lower blood glucose levels, providing assistance for blood glucose management. This can serve as a useful treatment option for patients who struggle with blood glucose control. Consistent use, along with healthy lifestyle habits, can contribute to improved blood glucose levels.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients who are unable to achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current dose of metformin. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be started at the patient's current doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and the dose adjusted as appropriate. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other glucose-lowering agents. Since such changes may cause alterations in glycemic control, any changes in the treatment of patients with type 2 diabetes mellitus should be made under close monitoring. To maintain its extended-release properties, this medicine should be swallowed whole and must not be split, crushed, ground, or chewed.

Precautions

This medication is used to treat diabetes and assist with blood glucose control. However, it should not be used in patients with poor kidney function or severe heart disease or liver dysfunction. In particular, in cases of decreased kidney function, the medication can accumulate in the body and cause lactic acidosis, which is a potentially dangerous condition, so caution is needed. Additionally, when used along with other diabetes medications, hypoglycemia may occur, so blood glucose levels should be closely monitored. Before and after surgery or radiographic tests involving contrast agents, medication use should be temporarily stopped and restarted only after confirming normal kidney function. Women who are pregnant or may become pregnant, as well as breastfeeding women, should avoid using this medication. Alcohol consumption should be avoided while taking this medication, and if symptoms such as dizziness, abdominal pain, or difficulty breathing occur, immediate consultation with medical personnel is necessary. Older adults may have decreased kidney function, so regular kidney function tests and appropriate dosage adjustments are required. Also, this medication may lower vitamin B12 levels, so periodic blood tests are needed for monitoring during long-term use. While taking this medication, sufficient knowledge of hypoglycemic symptoms and measures should be acquired, and caution is needed when driving or performing high-risk work. Furthermore, drug interactions may occur when used in combination with other medications, so any concurrent medications should be disclosed to medical personnel.

Side effects

  • Severe lactic acidosis
  • severe hypoglycemia
  • hypoglycemia
  • constipation
  • intestinal obstruction
  • liver dysfunction
  • interstitial pneumonia
  • similar blistering dermatitis
  • acute pancreatitis
  • dizziness
Show 184 more
  • abdominal distension
  • abdominal discomfort
  • nausea
  • abdominal pain
  • bloating
  • stomatitis
  • gastric polyps
  • colon polyps
  • duodenal ulcer
  • gastroesophageal reflux disease
  • diarrhea
  • decreased appetite
  • elevated amylase
  • elevated lipase
  • elevated AST (GOT)
  • elevated ALT (GPT)
  • elevated GGT
  • elevated ALP
  • proteinuria
  • ketonuria
  • potential hematuria
  • eczema
  • rash
  • itching
  • allergic dermatitis
  • arthralgia
  • elevated CK (CPK)
  • elevated serum potassium concentration
  • lethargy
  • allergic rhinitis
  • elevated serum uric acid
  • peripheral edema
  • herpes zoster
  • limb pain
  • upper abdominal pain
  • gastritis
  • upper respiratory infection
  • tremor
  • headache
  • myasthenia
  • hunger
  • fatigue
  • facial edema
  • dyspepsia
  • nausea
  • viral upper respiratory infection
  • rhinitis
  • diaphoresis
  • diabetic retinopathy
  • visual impairment
  • cough
  • pulmonary congestion
  • dyspnea
  • drug overdose
  • benign prostatic hyperplasia
  • headache
  • cerebral infarction
  • hyperglycemia
  • liver biopsy
  • decreased neutrophil count
  • abnormal blood sugar
  • increased blood sugar
  • increased blood pressure
  • hepatic coma
  • lumbar spinal stenosis
  • intravertebral disc herniation
  • intravertebral disc disorder
  • spinal ligament ossification
  • spinal foraminal stenosis
  • rotator cuff syndrome
  • bladder mass
  • ureteral calculi
  • urinary stones
  • coronary artery disease
  • unstable angina
  • gastroesophageal reflux disease
  • gastric polyps
  • gastritis
  • biliary obstruction
  • chronic cholecystitis
  • soft tissue infection
  • pneumonia
  • cataract
  • depression
  • iliac artery stenosis
  • vertigo
  • benign prostatic hyperplasia
  • knee surgery
  • dizziness
  • diabetic neuropathy
  • paresthesia
  • headache
  • muscle weakness
  • lumbar pain
  • limb pain
  • lumbar spinal stenosis
  • tendinitis
  • cervical pain
  • bone pain
  • osteoarthritis
  • osteoporosis
  • muscle spasms
  • foot deformity
  • hypertrophic osteoarthritis
  • bursitis
  • spinal osteoarthritis
  • intravertebral disc herniation
  • intravertebral disc disorder
  • spinal ligament ossification
  • spinal foraminal stenosis
  • postmenopausal osteoporosis
  • rotator cuff syndrome
  • herpes zoster
  • upper respiratory infection
  • gastroenteritis
  • pneumonia
  • H1N1 influenza
  • bronchitis
  • chronic sinusitis
  • folliculitis
  • cystitis
  • soft tissue infection
  • urinary tract infection
  • pharyngitis
  • streptococcal infection
  • tinea pedis
  • subcutaneous abscess
  • Helicobacter gastritis
  • vomiting
  • chronic gastritis
  • upper abdominal pain
  • stomatitis
  • esophagitis
  • gastrointestinal motility disorder
  • gastrointestinal motility decrease
  • enteritis
  • toothache
  • anal rectal discomfort
  • acquired mixed hyperlipidemia
  • hypertriglyceridemia
  • vitamin D deficiency
  • abnormal weight gain
  • essential hypertension
  • orthostatic hypotension
  • white coat hypertension
  • bleeding
  • increased blood sugar
  • abnormal sputum
  • increased blood creatinine
  • increased blood urea
  • anemia
  • atrial fibrillation
  • hypothyroidism
  • pressure sore ulcer
  • glaucoma
  • blurred vision
  • age-related macular degeneration
  • hyperthyroidism
  • hyperparathyroidism
  • coronary artery disease
  • unstable angina
  • angina
  • otalgia
  • vertigo
  • iron deficiency anemia
  • food allergy
  • gastroenteritis
  • influenza
  • uterine purulence
  • subcutaneous abscess
  • musculoskeletal chest pain
  • falls
  • animal bites
  • radial fracture
  • hearing loss
  • endolymphatic hydrops
  • vertigo
  • increased blood creatinine
  • increased blood urea
  • anemia
  • atrial fibrillation
  • hypothyroidism
  • dyspepsia
  • pressure sore ulcer

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container that is well-ventilated, and kept at a temperature between 1 and 30 degrees Celsius. Proper storage helps to maintain the medication's efficacy and prevent deterioration.

Appearance and packaging

Appearance

Yellow oval extended release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.